Evidence map›Paper›PMID 26104511›Full record

Observational studyDiagnostic pathology2015

Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.

Mohammed Sekal, Hassania Ameurtesse, Laila Chbani, Karim Ouldim, Sanae Bennis, Mohammed Abkari, Amal Boulouz, Dafr Allah Benajah, Basher Benjelloun, Abdelmalek Ousadden and 10 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Diagnostic pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Mohammed SekalDepartment of pathology, University hospital Hassan II of Fez, Fez, Morocco. doc.med@hotmail.com.
Hassania AmeurtesseDepartment of pathology, University hospital Hassan II of Fez, Fez, Morocco. ameurtesse@yahoo.com.
Laila ChbaniDepartment of pathology, University hospital Hassan II of Fez, Fez, Morocco. chbanil@yahoo.fr.
Karim OuldimDepartment of molecular genetics, University hospital Hassan II of Fez, Fez, Morocco. ouldim@yahoo.fr.
Sanae BennisDepartment of molecular genetics, University hospital Hassan II of Fez, Fez, Morocco. sabennis@yahoo.fr.
Mohammed AbkariDepartment of gastroenterology, University hospital Hassan II of Fez, Fez, Morocco. yassine.abkari@gmail.com.
Amal BoulouzDepartment of molecular genetics, University hospital Hassan II of Fez, Fez, Morocco. gasparo_v@hotmail.fr.
Dafr Allah BenajahDepartment of gastroenterology, University hospital Hassan II of Fez, Fez, Morocco. dafrb@yahoo.fr.
Basher BenjellounDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. benjelloun19@hotmail.com.
Abdelmalek OusaddenDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. ousadden@yahoo.fr.
Khalid Ait TalebDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. khaittaleb@gmail.com.
Said Ait LaalimDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. aitlaalims@yahoo.fr.
Imane ToghraiDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. toughiman@hotmail.com.
Khalid MazazDepartment of visceral surgery, University hospital Hassan II of Fez, Fez, Morocco. khali.mazaz@gmail.com.
Samia ArifiDepartment of oncology, University hospital Hassan II of Fez, Fez, Morocco. drsarifi@yahoo.fr.
Nawfel MellasDepartment of oncology, University hospital Hassan II of Fez, Fez, Morocco. mellasnawfel@yahoo.fr.
Karima El RhaziDepartment of epidemiology, University hospital Hassan II of Fez, Fez, Morocco. elrhazikarima@gmail.com.
Taoufiq HarmouchDepartment of pathology, University hospital Hassan II of Fez, Fez, Morocco. taoufhar@yahoo.fr.
Sidi Adil IbrahimiDepartment of gastroenterology, University hospital Hassan II of Fez, Fez, Morocco. gastrochufes@hotmail.com.
Afaf Amarti RiffiDepartment of pathology, University hospital Hassan II of Fez, Fez, Morocco. amartiafaf@gmail.com.
Centre Hospitalier Universitaire Hassan II · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal Cancers (CRC) are one of the most common malignancies in the world. Their incidence in Morocco, between 2005 and 2007, was 5.6 for 100000 inhabitants, which is very low compared to what found in developed countries. In addition, CRCs show a high frequency of rectal localizations, and occurs in a younger population in Morocco compared to what found in developed countries. The purpose of this study is to confirm these CRC peculiarities in Morocco and try to explain them by exploring the microsatellite instability molecular pathway.

methodsThis is a prospective observational study conducted since January 2010, including 385 patients admitted in Hassan II University Hospital of Fez. We collected clinical, radiological and pathological data. We investigated the expression of mismatch repair (MMR) proteins in 214 patients and BRAF gene mutations in 159 patients.

resultsMean age was 55.08 +/- 15.16 years. 36.5% of patients were less than 50 years old and 49.3% of tumors were localized in the rectum. Loss of MMR protein expression was observed in 11.2% of cases. It was independently associated with individual or family history of cancer belonging to Hereditary Non-Polyposis Colorectal Cancer (HNPCC) spectrum (p = 0.01) and proximal localization (p = 0.02). No BRAF mutation was detected in all cases.

conclusionsThese results confirm the high occurrence of CRCs to young patients and the high frequency of rectal localizations in Moroccan population. They mostly show an absence of BRAF mutation, supposing a rarity of MLH1 promoter hypermethylation pathway, which may even partially explain the CRC peculiarities in our context. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5868184711716884.

Indexed as

Microsatellite InstabilityAdaptor Proteins, Signal TransducingAdenocarcinomaAdultAgedAge of OnsetBiomarkers, TumorColorectal NeoplasmsDeveloping CountriesDNA MethylationDNA Mismatch RepairDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseHospitals, UniversityHumansAdaptor Proteins, Signal TransducingBiomarkers, TumorBRAF protein, humanMLH1 protein, humanMutL Protein Homolog 1Nuclear ProteinsProto-Oncogene Proteins B-raf

Identifiers

PMID26104511
PMCPMC4477595
OpenAlexW1846452438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.